CVR number 30550366
Industry 869500

FysioDanmark Aalborg ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.4% 2.5% 2.5% 3.6% 2.3%  
Credit score (0-100)  54 60 62 51 64  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.1  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  17,214 18,554 20,765 20,839 22,564  
EBITDA  1,913 1,789 1,715 1,696 1,770  
EBIT  1,614 1,535 1,568 1,536 1,524  
Pre-tax profit (PTP)  1,673.1 1,570.4 1,495.4 980.3 1,500.1  
Net earnings  1,297.9 1,219.7 1,140.1 631.8 1,162.5  
Pre-tax profit without non-rec. items  1,673 1,570 1,495 980 1,500  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  594 506 505 713 1,251  
Shareholders equity total  2,377 2,597 2,514 1,946 2,408  
Interest-bearing liabilities  31.0 31.9 1,198 2,318 3,072  
Balance sheet total (assets)  7,992 6,836 7,761 8,154 8,464  
Net Debt  -1,392 -648 932 1,986 3,059  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  17,214 18,554 20,765 20,839 22,564  
Gross profit growth  2.1% 7.8% 11.9% 0.4% 8.3%  
Employees  35 35 36 35 35  
Employee growth %  -10.3% 0.0% 2.9% -2.8% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,992 6,836 7,761 8,154 8,464  
Balance sheet change%  10.8% -14.5% 13.5% 5.1% 3.8%  
Added value  1,913.4 1,789.3 1,715.4 1,682.6 1,769.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -564 -347 -153 46 291  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  9.4% 8.3% 7.6% 7.4% 6.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  22.8% 22.0% 21.9% 13.3% 20.2%  
ROI %  41.6% 43.3% 41.3% 24.9% 31.8%  
ROE %  58.3% 49.0% 44.6% 28.3% 53.4%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  29.8% 38.0% 32.4% 23.9% 28.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -72.7% -36.2% 54.3% 117.1% 172.8%  
Gearing %  1.3% 1.2% 47.6% 119.2% 127.6%  
Net interest  0 0 0 0 0  
Financing costs %  6.4% 189.6% 17.2% 4.5% 6.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.4 1.6 1.3 1.2 1.3  
Current Ratio  1.4 1.7 1.3 1.2 1.3  
Cash and cash equivalent  1,422.7 679.8 265.6 332.1 13.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,820.0 2,021.0 1,136.3 1,026.7 1,342.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  55 51 48 48 51  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  55 51 48 48 51  
EBIT / employee  46 44 44 44 44  
Net earnings / employee  37 35 32 18 33